Cargando…
Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection
Both dual time-point (99m)Tc-hexamethylpropylene amine oxime (HMPAO)-leukocyte scintigraphy and dual-tracer (99m)Tc-HMPAO-leukocyte scintigraphy (with the addition of (99m)Tc-nanocolloid bone marrow scintigraphy) have been used to diagnose prosthetic joint infection (PJI). A treatment evaluation of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191474/ https://www.ncbi.nlm.nih.gov/pubmed/33741868 http://dx.doi.org/10.1097/MNM.0000000000001403 |
_version_ | 1783705877193162752 |
---|---|
author | Teiler, Johan Åkerlund, Börje Brismar, Harald Savitcheva, Irina Ahl, Marcus Bjäreback, Annie Hedlund, Håkan Holstensson, Maria Axelsson, Rimma |
author_facet | Teiler, Johan Åkerlund, Börje Brismar, Harald Savitcheva, Irina Ahl, Marcus Bjäreback, Annie Hedlund, Håkan Holstensson, Maria Axelsson, Rimma |
author_sort | Teiler, Johan |
collection | PubMed |
description | Both dual time-point (99m)Tc-hexamethylpropylene amine oxime (HMPAO)-leukocyte scintigraphy and dual-tracer (99m)Tc-HMPAO-leukocyte scintigraphy (with the addition of (99m)Tc-nanocolloid bone marrow scintigraphy) have been used to diagnose prosthetic joint infection (PJI). A treatment evaluation of persistent PJI using these imaging protocols has yet to be presented. OBJECTIVE: The purpose of this study was to compare the accuracy of dual time-point (99m)Tc-HMPAO-leukocyte scintigraphy to the dual-tracer alternative of single time-point (99m)Tc-HMPAO-leukocyte scintigraphy or single-photon emission computed tomography/computed tomography (SPECT/CT) combined with a (99m)Tc-nanocolloid bone marrow scintigraphy or SPECT/CT, for treatment evaluation of PJI. MATERIAL AND METHODS: Thirty-one PJI patients under antibiotic treatment were included in this retrospective study. Examinations were organized into three settings. Setting one used dual time-point approach with delayed (2 h) and late (24 h) planar (99m)Tc-HMPAO-leukocyte scintigraphy, including both visual and semiquantitative analysis. Setting two used delayed (2 h) planar (99m)Tc-HMPAO-leukocyte scintigraphy combined with (99m)Tc-nanocolloid bone marrow scintigraphy and for setting three SPECT/CT replaced planar imaging. RESULTS: Accuracy was 0.68 for visual evaluation and 0.55 for semiquantitative evaluation of setting one; 0.71 for setting two; and 0.68 for setting three. Sensitivity was 0.54 for visual evaluation and 0.31 for semiquantitative evaluation of setting one; 0.38 for setting two; and 0.46 for setting three. Specificity was 0.78 for visual evaluation and 0.72 for semiquantitative evaluation of setting one; 0.94 for setting two; and 0.83 for setting three. CONCLUSION: No significant difference in accuracy, sensitivity, or specificity between the approaches for treatment evaluation of suspected persistent PJI in the hip or knee was observed. |
format | Online Article Text |
id | pubmed-8191474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-81914742021-06-16 Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection Teiler, Johan Åkerlund, Börje Brismar, Harald Savitcheva, Irina Ahl, Marcus Bjäreback, Annie Hedlund, Håkan Holstensson, Maria Axelsson, Rimma Nucl Med Commun Original Articles Both dual time-point (99m)Tc-hexamethylpropylene amine oxime (HMPAO)-leukocyte scintigraphy and dual-tracer (99m)Tc-HMPAO-leukocyte scintigraphy (with the addition of (99m)Tc-nanocolloid bone marrow scintigraphy) have been used to diagnose prosthetic joint infection (PJI). A treatment evaluation of persistent PJI using these imaging protocols has yet to be presented. OBJECTIVE: The purpose of this study was to compare the accuracy of dual time-point (99m)Tc-HMPAO-leukocyte scintigraphy to the dual-tracer alternative of single time-point (99m)Tc-HMPAO-leukocyte scintigraphy or single-photon emission computed tomography/computed tomography (SPECT/CT) combined with a (99m)Tc-nanocolloid bone marrow scintigraphy or SPECT/CT, for treatment evaluation of PJI. MATERIAL AND METHODS: Thirty-one PJI patients under antibiotic treatment were included in this retrospective study. Examinations were organized into three settings. Setting one used dual time-point approach with delayed (2 h) and late (24 h) planar (99m)Tc-HMPAO-leukocyte scintigraphy, including both visual and semiquantitative analysis. Setting two used delayed (2 h) planar (99m)Tc-HMPAO-leukocyte scintigraphy combined with (99m)Tc-nanocolloid bone marrow scintigraphy and for setting three SPECT/CT replaced planar imaging. RESULTS: Accuracy was 0.68 for visual evaluation and 0.55 for semiquantitative evaluation of setting one; 0.71 for setting two; and 0.68 for setting three. Sensitivity was 0.54 for visual evaluation and 0.31 for semiquantitative evaluation of setting one; 0.38 for setting two; and 0.46 for setting three. Specificity was 0.78 for visual evaluation and 0.72 for semiquantitative evaluation of setting one; 0.94 for setting two; and 0.83 for setting three. CONCLUSION: No significant difference in accuracy, sensitivity, or specificity between the approaches for treatment evaluation of suspected persistent PJI in the hip or knee was observed. Lippincott Williams & Wilkins 2021-03-12 2021-07 /pmc/articles/PMC8191474/ /pubmed/33741868 http://dx.doi.org/10.1097/MNM.0000000000001403 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Articles Teiler, Johan Åkerlund, Börje Brismar, Harald Savitcheva, Irina Ahl, Marcus Bjäreback, Annie Hedlund, Håkan Holstensson, Maria Axelsson, Rimma Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection |
title | Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection |
title_full | Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection |
title_fullStr | Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection |
title_full_unstemmed | Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection |
title_short | Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection |
title_sort | dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191474/ https://www.ncbi.nlm.nih.gov/pubmed/33741868 http://dx.doi.org/10.1097/MNM.0000000000001403 |
work_keys_str_mv | AT teilerjohan dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection AT akerlundborje dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection AT brismarharald dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection AT savitchevairina dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection AT ahlmarcus dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection AT bjarebackannie dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection AT hedlundhakan dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection AT holstenssonmaria dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection AT axelssonrimma dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection |